| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/25/2008 | EP1033996B1 Prevention and treatment of amyloidogenic disease |
| 06/25/2008 | EP0988051B1 Lyme combination compositions and uses |
| 06/25/2008 | EP0859625B1 Composition and methods for enhancing immune responses mediated by antigen-presenting cells |
| 06/25/2008 | EP0851920B1 Variants of vascular endothelial cell growth factor, their uses, and processes for their porduction |
| 06/25/2008 | EP0805859B2 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. |
| 06/25/2008 | CN101208355A Treatment of fungal and/or protist infections |
| 06/25/2008 | CN101208354A Epidermal growth factor receptor mutations |
| 06/25/2008 | CN101208353A Isoforms of brain natriuretic peptide |
| 06/25/2008 | CN101208100A Anti-malaria vaccine |
| 06/25/2008 | CN101208099A Biosynthetic polypeptides utilizing non-naturally encoded amino acids |
| 06/25/2008 | CN101205252A Soluble V E G F R bifunctional chimera receptor, preparation method and uses thereof |
| 06/25/2008 | CN101205251A Chinese south China sea signal taro snail nerve toxin gene Lt3.2 and uses thereof |
| 06/25/2008 | CN101205250A Method for preparing high-purity apolipoprotein A-I |
| 06/25/2008 | CN100397082C HCV-free-blood external preparing method |
| 06/25/2008 | CN100397081C Diagnosing tumorigenicity and determining resistance to the antineoplastic therapy |
| 06/25/2008 | CN100396784C Methods of inducing the expression of bone morphogenetic proteins (BMPs) and transforming growth factor-beta-proteins (TGF-ª‰s) in cells |
| 06/25/2008 | CN100396698C New mastocancer related protein and its specificity multiclone antibody |
| 06/25/2008 | CN100396697C New mastocancer related protein and its specificity multiclone antibody |
| 06/25/2008 | CN100396696C Use of ocean green algae in extraction of cyclic peptide components with anti-tumor activity |
| 06/25/2008 | CN100396695C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 06/24/2008 | US7392141 Polypeptides; genetic engineering |
| 06/24/2008 | US7390944 Inbred corn line G06-NP2739 |
| 06/24/2008 | US7390943 Inbred corn line G06-NP2598 |
| 06/24/2008 | US7390937 Plants with enhanced levels of nitrogen utilization proteins in their root epidermis and uses thereof |
| 06/24/2008 | US7390895 Rapamycin analogues; diabetes, acute or chronic rejection of an organ or tissue transplant, asthma, tumours, psoriasis, eczema, rheumatoid arthritis, fibrosis, and allergies |
| 06/24/2008 | US7390894 Glutathione S-transferase sequence variants |
| 06/24/2008 | US7390888 Dendritic cell potentiation |
| 06/24/2008 | US7390887 Antibodies against PRO4330 |
| 06/24/2008 | US7390886 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of tumor and cell proliferative disorders |
| 06/24/2008 | US7390883 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by skeletal cells/adipocytes; for stimulating the release of proteoglycans from cartilage |
| 06/24/2008 | US7390881 first component is the modified antigenic ectodomain of measles virus hemagglutinin protein, second component fused to first component that binds a surface protein of human immunodeficiency virus; for treating HIV infection and other therapeutic targets against which it is difficult to develop vaccines |
| 06/24/2008 | US7390880 Soluble interleukin-1 receptor accessory molecule |
| 06/24/2008 | US7390879 Conjugation/biochemical; fibroblast growth factors |
| 06/24/2008 | US7390878 PRO6090 polypeptides |
| 06/24/2008 | US7390877 Vectors with DNA encoding pro polypeptides |
| 06/24/2008 | US7390876 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 06/24/2008 | US7390875 Method for binding, in solution, a peptide and a lipophilic vector and uses thereof |
| 06/24/2008 | US7390874 Peptide, method of production thereof, and pharmaceutical composition containing the same |
| 06/24/2008 | US7390873 Microbiocides; bactericides |
| 06/24/2008 | US7390872 fusion proteins has high transduction potential, inhibits the NF- kappa B pathway; biodrugs as antiinflammatory agents, viricides, antiproliferative agents, immunostimulants |
| 06/24/2008 | US7390871 Isolated polypeptide as antitumor agents, anticarcinogenic agents; amino acid sequences binding to major histocompatibility complex (MHC); tumor antigen induces killer T cells against cancer; anti-cancer vaccines, biodrugs |
| 06/24/2008 | US7390787 Comprising 8 to 25 amino acids and containing the formula: RXZXXZXB wherein Z is proline or valine; X is a hydrophobic residue; and B is a basic amino acid. |
| 06/24/2008 | US7390785 Amino acid sequences; from venom of snails; analgesics |
| 06/24/2008 | US7390782 Methods and products related to metabolic interactions in disease |
| 06/24/2008 | US7390781 Methods of using truncated glial cell line-derived neurotrophic factor |
| 06/24/2008 | US7390656 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 06/24/2008 | US7390653 Apparatus for propagation of cells/tissues and generation of preferential proteins; bioreactors |
| 06/24/2008 | US7390645 Lactose repressor proteins with increased operator DNA binding affinity |
| 06/24/2008 | US7390643 Geranyl diphosphate synthase molecules, and nucleic acid molecules encoding same |
| 06/24/2008 | US7390638 A polynucleotide encoding a carboxy-truncated interferon gamma (IFNG) polypeptide mutant exhibiting IFNG receptor binding activity having the amino acid sequence, SEQ ID NO:12, or 1-10 residue modifications; antitumor, -carcinogenic agent; viricides; interstitial lung diseases; autoimmune diseases |
| 06/24/2008 | US7390637 Keratinocyte derived interferon |
| 06/24/2008 | US7390636 Method for construction and use of Kluyveromyces lactis promoter variants in K. lactis that substantially lack E. coli transcriptional capability |
| 06/24/2008 | US7390634 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
| 06/24/2008 | US7390632 Soluble ErbB3 receptor isoforms |
| 06/24/2008 | US7390625 Apoptosis-associated protein and use thereof |
| 06/24/2008 | US7390624 For immunoglobulin detection; for diagnosis of human immunodeficiency virus and hepatitis virus; solid phase synthesis |
| 06/24/2008 | US7390619 Creating a library of mutant polynucleotides from at least two nucleic acids encoding a B7-1 (CD80) protein; expressing in cells and screening for the optimized polynucleotide; increased T-cell response, increased activity through CD28 and a decreased activity through CTLA-4 |
| 06/24/2008 | US7390494 Vaccine comprises nucleic acid encodes an immunogenic protein that induces a protective response effective against infection by a piglet weight loss disease circovirus; structural and non-structural polypeptides, vectors, and cells transformed by the vectors; kits for diagnosing |
| 06/24/2008 | US7390493 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 06/24/2008 | US7390492 Producing a passive immunity vaccine against Sarcocystis neurona by providing Sarcocystis neurona 16 kDa and 30 kDa antigens as determined by SDS polyacrylamide gel electrophoresis;immunizing mammal in mixture with adjuvant; removing serum; isolating antibodies; administering antibodies |
| 06/24/2008 | US7390488 Administering platelet binding agent; complexing; activation of complex; thrombosis |
| 06/24/2008 | US7390487 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| 06/24/2008 | US7390486 PRO4381 antibodies |
| 06/24/2008 | US7390482 Drug for auditory dysfunction |
| 06/24/2008 | US7390481 Mammalian cytokine complexes |
| 06/19/2008 | WO2008073877A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 06/19/2008 | WO2008073617A2 Increasing tolerance of plants to low light conditions |
| 06/19/2008 | WO2008073578A2 Plant genes involved in nitrate uptake and metabolism |
| 06/19/2008 | WO2008073463A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 06/19/2008 | WO2008073161A2 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 06/19/2008 | WO2008072075A2 Transferrin fusion protein libraries |
| 06/19/2008 | WO2008072000A2 Use of integrin alpha 10 binding antibody to modulate extracellular matrix ( cartilage) turnover |
| 06/19/2008 | WO2008071972A1 Novel compounds and their effects on feeding behaviour |
| 06/19/2008 | WO2008071934A1 Treatment of cachexia |
| 06/19/2008 | WO2008071774A1 Purification process for coat protein of rna bacteriophages |
| 06/19/2008 | WO2008071767A1 Plants having enhanced seed yield-related traits and a method for making the same |
| 06/19/2008 | WO2008071755A2 Casein-derived peptides having anxiolytic activity |
| 06/19/2008 | WO2008071723A1 A homogeneous time resolved fluorescence based test system for paramyxoviridae |
| 06/19/2008 | WO2008071447A2 Amino acid sequences that modulate the interaction between cells of the immune system |
| 06/19/2008 | WO2008071201A1 Transgenic animal model for modelling pathological anxiety, a method for identifying compounds for treatment of diseases or disorders caused by pathological anxiety and a method for using wfsl protein as a target for identifying effective compounds against pathological anxiety |
| 06/19/2008 | WO2008070927A1 Multimeric fc receptor polypeptides including a modified fc domain |
| 06/19/2008 | WO2008070893A1 Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system |
| 06/19/2008 | WO2008070892A1 Promoting production of extracellular matrix by fibroblast cells and/or promoting migration of fibroblast cells |
| 06/19/2008 | WO2008051526A9 Bone morphogenetic proteins |
| 06/19/2008 | WO2008050139A3 Laminin binding site |
| 06/19/2008 | WO2008050133A3 Inhibition of beta-amyloid aggregation |
| 06/19/2008 | WO2008049974A8 Peptide vaccine for influenza virus |
| 06/19/2008 | WO2008046189A9 Proteins involved in after-cooking darkening in potatoes |
| 06/19/2008 | WO2008041107A3 Fluorescent proteins from the ctenophora phylum and methods of use thereof |
| 06/19/2008 | WO2008036973A3 Modulating regulatory t cell activity via interleukin 35 |
| 06/19/2008 | WO2008027807A3 Control of diabetes and obesity |
| 06/19/2008 | WO2008015692A3 MOLECULAR CLONING AND SEQUENCING OF ACETYL CoA CARBOXYLASE (ACCase) GENE FROM JATROPHA CURCAS |
| 06/19/2008 | WO2007149529A3 Thrombopoietic compounds |
| 06/19/2008 | WO2007147029A3 Axmi-031, axmi-039, axmi-040 and axmi-049, a family of delta-endotoxin genes and methods for their use |
| 06/19/2008 | WO2007141516A3 Influenza virus neuraminidase crystal structure and their use thereof |
| 06/19/2008 | WO2007099446A3 Virosome-like vesicles comprising gp41-derived antigens |
| 06/19/2008 | WO2001034766A3 Protein monitoring the activity of small gtp-binding protein |
| 06/19/2008 | US20080148433 Expression vector comprising nucleotide sequences coding malonyl-CoA:ACP acyltransferase (MAT), beta -keto acyl-ACP synthase (KS) and ketoreductase (KR) for transforming and propagating cells with enhanced concentrations of polyunsaturated fatty acid (PUFA) |
| 06/19/2008 | US20080148431 Herbicide resistant picea comprising expression vector coding prephenate dehydrogenase for use as bioreactor for synthesis of tyrosine |
| 06/19/2008 | US20080148430 Using transgenic plants as bioreactor for measuring or detecting mitogen-activated protein (MAP) kinase activity |